Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Leukemia & Lymphoma|November 1, 1995
Performance of CD3xCD19 bispecific monoclonal antibodies in B cell malignancyI A HaagenPractical Laboratory Medicine|July 9, 2020
Analytical and clinical performance of the fully-automated LIAISONXL calprotectin immunoassay from DiaSorin in IBD patientsR Vicente-Steijn, J M Jansen, R Bisheshar, et al.Journal of Immunology (Baltimore, Md. : 1950)|February 15, 1995
Interaction of human monocyte Fc gamma receptors with rat IgG2b. A new indicator for the Fc gamma RIIa (R-H131) polymorphismI A Haagen, A J Geerars, M R Clark, et al.The Journal of Infectious Diseases|February 1, 1990
Adherence of peritonitis-causing staphylococci to human peritoneal mesothelial cell monolayersI A Haagen, H C Heezius, R P Verkooyen, et al.Clinical and Experimental Immunology|December 1, 1992
Killing of human leukaemia/lymphoma B cells by activated cytotoxic T lymphocytes in the presence of a bispecific monoclonal antibody (alpha CD3/alpha CD19)I A Haagen, R van de Griend, M Clark, et al.Blood|June 1, 1995
The efficacy of CD3 x CD19 bispecific monoclonal antibody (BsAb) in a clonogenic assay: the effect of repeated addition of BsAb and interleukin-2I A Haagen, A J Geerars, W B de Lau, et al.Cancer Immunology, Immunotherapy : CII|December 1, 1994
Unprimed CD4+ and CD8+ T cells can be rapidly activated by a CD3 x CD19 bispecific antibody to proliferate and become cytotoxicI A Haagen, W B de Lau, B J Bast, et al.Cancer Research|June 15, 1991
No expansion of the pre-B and B-cell compartments in the bone marrow of patients with multiple myelomaC Duperray, R Bataille, J M Boiron, et al.Proceedings of the National Academy of Sciences of the United States of America|May 30, 1998
PU.1 as an essential activator for the expression of gp91(phox) gene in human peripheral neutrophils, monocytes, and B lymphocytesS Suzuki, A Kumatori, I A Haagen, et al.Therapeutic Immunology|October 1, 1994
Evaluation of Fc gamma receptor mediated T-cell activation by two purified CD3 x CD19 bispecific monoclonal antibodies with hybrid Fc domainsI A Haagen, A J Geerars, E J Bast, et al.Pageof 2